BAO QUOC NGUYEN, DMD
Dentist at Linda Vista Rd, San Diego, CA

License number

California 34176

Professional information

Technical Account Manager

Location:

Greater San Diego Area

Industry:

Telecommunications

Skills:

CDMA

Software Engineer

Position:

VMS Software Engineer at Northrop Grumman Aerospace Systems

Location:

San Diego, California

Industry:

Aviation & Aerospace

Work:

Northrop Grumman Aerospace Systems since Nov 2011 - VMS Software Engineer The Boeing Company Nov 2003 - Nov 2011 - Embedded Software Engineer Boingo Wireless Jun 2003 - Oct 2003 - Engineering Intern NCR Corporation Jun 2002 - Sep 2002 - Software Engineer Intern NCR Corporation Jun 2001 - Sep 2001 - Electrical Engineer Intern

Education:

Loyola Marymount University 2005 - 2009
Master of Science, Electrial Engineering University of California, Los Angeles 1999 - 2003
Bachelor of Science, Electrical Engineering University of California, Irvine

Skills:

C++, Embedded Software, Embedded Systems, Requirements Analysis, Aerospace, Avionics

Technician At Ups

Position:

Technician at UPS

Location:

Greater San Diego Area

Industry:

Information Technology and Services

Work:

UPS - Technician

Education:

University of Massachusetts at Lowell 1995 - 1997

Bao Quoc Nguyen, San Diego CA

Specialties:

Dentist

Address:

6947 Linda Vista Rd, San Diego, CA 92111

Network Selection Methods And Apparatus With Home Network Prioritization After Network Signal Recovery Or Power-On

US Patent:

2011002, Jan 27, 2011

Filed:

Oct 4, 2010

Appl. No.:

12/897527

Inventors:

Jayasri Gunaratnam - Waterloo, CA
Noushad S. Naqvi - Waterloo, CA
Bryan Taylor - Kitchener, CA
Craig Ian Haight Swann - Waterloo, CA
Hugh R. Hind - Waterloo, CA
Bao Quoc Nguyen - San Diego CA, US
Darcy Richard Phipps - Waterloo, CA

Assignee:

RESEARCH IN MOTION LIMITED - Waterloo

International Classification:

H04W 4/00

US Classification:

455433

Abstract:

A network selection method for a mobile station which is associated with a Home Public Land Mobile Network (HPLMN) identified by a home Mobile Network Code (MNC) and Mobile Country Code (MCC) pair. The mobile station identifies a plurality of PLMNs in a geographic area, and selects a non-home PLMN identified by a non-home MNC/MCC pair and designated as a Registered PLMN (RPLMN). In response to regaining signal coverage from an out-of-coverage condition with the RPLMN, or being powered-on from a power-off state entered while operating with the RPLMN, the mobile station selects the HPLMN if the HPLMN identified by the home MNC/MCC pair is available. Otherwise, if the HPLMN is unavailable and the RPLMN identified by the non-home MNC/MCC pair is available, the mobile station selects the RPLMN. However, if the RPLMN is unavailable, the mobile station selects an alternate PLMN in accordance with an automatic or manual network selection method.

Compounds And Compositions As C-Kit Kinase Inhibitors

US Patent:

2013005, Mar 7, 2013

Filed:

Aug 27, 2012

Appl. No.:

13/595575

Inventors:

Vince YEH - San Diego CA, US
Xiaolin LI - Emeryville CA, US
Xiaodong LIU - San Diego CA, US
Jon LOREN - San Diego CA, US
Valentina MOLTENI - San Diego CA, US
Juliet NABAKKA - San Diego CA, US
Bao NGUYEN - San Diego CA, US
Hank Michael James PETRASSI - Cardiff CA, US

Assignee:

IRM LLC - Hamilton

International Classification:

A61K 31/437, A61K 31/496, A61K 31/5377, A61P 19/04, A61P 11/00, A61P 1/00, A61P 37/06, A61P 3/00, A61P 21/00, A61P 17/00, A61P 9/12, A61P 11/06, A61P 37/08, A61P 9/00, A61P 3/10, C07D 471/04

US Classification:

5142332, 546121, 514300, 544362, 51425304, 544127, 546 15

Abstract:

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRα, PDGFRβ) kinases.

Substituted 2-Aryl-4-Arylaminopyrimidines And Analogs As Activators Of Caspases And Inducers Of Apoptosis And The Use Thereof

US Patent:

7226927, Jun 5, 2007

Filed:

Nov 10, 2003

Appl. No.:

10/704448

Inventors:

Sui Xiong Cai - San Diego CA, US
John A Drewe - Carlsbad CA, US
P. Sanjeeva Reddy - San Diego CA, US
Bao Nguyen - San Diego CA, US
Azra Pervin - San Marcos CA, US

Assignee:

Cytovia, Inc. - San Diego CA

International Classification:

A61K 31/53, A61K 31/505, A61K 31/506, C07D 239/02, C07D 409/00, C07D 251/00, C07C 49/00, C07C 255/17

US Classification:

514256, 514241, 544180, 544326, 544328

Abstract:

The present invention is directed to substituted 2-aryl-4-arylaminopyrimidine and analogs thereof, represented by the general Formula I:.

Thrombopoietin Activity Modulating Compounds And Methods

US Patent:

2008010, May 1, 2008

Filed:

Dec 21, 2007

Appl. No.:

11/963115

Inventors:

E. Kallel - Escondido CA, US
Thomas Lau - San Diego CA, US
Matthew McNeill - San Clemente CA, US
Todd Miller - San Marcos CA, US
Bao Nguyen - San Diego CA, US
Richard Penuliar - San Diego CA, US
Dean Phillips - San Marcos CA, US
Daniel Ruppar - San Antonio TX, US
Lin Zhi - San Diego CA, US
Jackline Dalgard - Del Mar CA, US

Assignee:

Ligand Pharmaceuticals, Inc. - San Diego CA

International Classification:

A61K 31/404, A61P 7/00, C07D 209/30, C12N 5/00, G01N 33/53

US Classification:

514418000, 435375000, 435004000, 548486000

Abstract:

Disclosed herein are compounds, pharmaceutical compositions comprising the same, methods of modulating the activity a thrombopoietin receptor using the same, methods of identifying compounds as thrombopoietin receptor modulators, and methods of treating disease by administering a compound of the invention to a patient in need thereof.

Microdevice Arrays Formed By Magnetic Assembly

US Patent:

2008017, Jul 24, 2008

Filed:

Jan 23, 2008

Appl. No.:

12/018319

Inventors:

Christopher D. Herold - Del Mar CA, US
David Rothwarf - La Jolla CA, US
Bao Nguyen - San Diego CA, US

Assignee:

ARRAYOMICS, INC. - San Diego CA

International Classification:

C40B 50/00, C40B 60/14, C40B 40/00

US Classification:

506 13, 506 40, 506 23

Abstract:

Microdevices containing a predetermined preferential axis of magnetization are disposed in an array having discreet regions. Under influence of a magnetic field, the microdevices can have at least twelve discrete orientations, and can advantageously be flipped upside down in place. Microdevices can be coded in a manner that supports a coding space of at least 10, 10, 10or even 10or more choices, and can include one or more chemically reactive sites. The regions can be defined by long and short bars, in which microdevices span gaps between the longer bars, and the shorter bars measure less than 60% of such gaps. Preferred embodiments are also provided to produce microfabricated microdevices for magnetic assembly-based arraying.